| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Zeif Yoav | Chief Executive Officer | C/O STRATASYS LTD., 1 HOLTZMAN STREET, SCIENCE PARK, REHOVOT, ISRAEL | /s/ Vered Ben Jacob, attorney-in-fact | 18 Mar 2026 | 0001972642 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | SSYS | Ordinary shares | 151,083 | 18 Mar 2026 | Direct | ||||||
| holding | SSYS | Ordinary shares | 36,667 | 18 Mar 2026 | Direct | F1 | |||||
| holding | SSYS | Ordinary shares | 36,667 | 18 Mar 2026 | Direct | F2 | |||||
| holding | SSYS | Ordinary shares | 36,667 | 18 Mar 2026 | Direct | F3 | |||||
| holding | SSYS | Ordinary shares | 70,475 | 18 Mar 2026 | Direct | F4 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | SSYS | Stock Option (right to buy ordinary shares) | 18 Mar 2026 | Ordinary shares | 150,000 | $16.41 | Direct | F5 | ||||||
| holding | SSYS | Stock Option (right to buy ordinary shares) | 18 Mar 2026 | Ordinary shares | 150,000 | $16.41 | Direct | F6 |
| Id | Content |
|---|---|
| F1 | The ordinary shares reported in this row consist of shares underlying restricted share units ("RSUs") that were granted to the Reporting Person on March 1, 2023 and that vest and settle for underlying ordinary shares in accordance with the following schedule: 25% of the RSUs vest upon the one-year anniversary of the grant date, and the remaining RSUs vest equally on a quarterly basis over the following twelve quarters (6.25% per quarter) whereby all such RSUs will be fully vested (and underlying ordinary shares issued) by the four-year anniversary of the grant date. |
| F2 | The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person on December 21, 2023 and that vest and settle for underlying ordinary shares in accordance with the following schedule: 25% of the RSUs vest upon the one-year anniversary of the grant date and the remaining RSUs vest equally on a quarterly basis over the following twelve quarters (6.25% per quarter) whereby all such RSUs will be fully vested (and underlying ordinary shares issued) by the four-year anniversary of the grant date. |
| F3 | The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person on December 19, 2024 and that vest and settle for underlying ordinary shares in accordance with the following schedule: 25% of the RSUs vest upon the one-year anniversary of the grant date and the remaining RSUs vest equally on a quarterly basis over the following twelve quarters (6.25% per quarter) whereby all such RSUs will be fully vested (and underlying ordinary shares issued) by the four-year anniversary of the grant date. |
| F4 | The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person on September 30, 2025 and that vest and settle for underlying ordinary shares in accordance with the following schedule: 25% of the RSUs vest upon the one-year anniversary of the grant date and the remaining RSUs vest equally on a quarterly basis over the following twelve quarters (6.25% per quarter) whereby all such RSUs will be fully vested (and underlying ordinary shares issued) by the four-year anniversary of the grant date. |
| F5 | The options reported in this row were granted to the Reporting Person by the Issuer on February 18, 2020 and vest and become exercisable subject to the Issuer's share price reaching a certain level, in equal installments of 18,750 options each over a period of eight quarters following achievement of the share price level, such that at the end of such eight quarter period all 150,000 options will be fully vested and exercisable. |
| F6 | The options reported in this row were granted to the Reporting Person by the Issuer on February 18, 2020 and vest and become exercisable subject to the Issuer's share price reaching a certain level, in equal installments of 18,750 options each over a period of eight quarters following achievement of the share price level, such that at the end of such eight quarter period all 150,000 options will be fully vested and exercisable. |